Skip NavigationSkip to Content

IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

  1. Author:
    Tamm, I.
    Wang, Y.
    Sausville, E.
    Scudiero, D. A.
    Vigna, N.
    Oltersdorf, T.
    Reed, J. C.
  2. Author Address

    Reed JC Burnham Inst 10901 N Torrey Pines Rd La Jolla, CA 92037 USA Burnham Inst La Jolla, CA 92037 USA Idun Pharmaceut La Jolla, CA 92037 USA NCI, Frederick Canc Res & Dev Ctr, Dev Therapeut Program Frederick, MD 21702 USA
    1. Year: 1998
  1. Journal: Cancer Research
    1. 58
    2. 23
    3. Pages: 5315-5320
  2. Type of Article: Article
  1. Abstract:

    Survivin is a member of the inhibitor of apoptosis protein (IAP) family. We investigated the antiapoptotic mechanism of Survivin, as well as its expression in 60 human tumor cell Lines used for the National Cancer Institute's anticancer drug screening program. In cotransfection experiments, cell death induced by Bar or Fas (CD 95) was partially inhibited (mean +/- SD, 65% +/- 8%) by Sunivin, whereas XIAP, another IAP family member, almost completely blocked cell death (93% +/- 4%) under the same conditions. Survivin and XIAP also protected 293 cells from apoptosis induced by overexpression of procaspase-3 and -7 and inhibited the processing of these zymogens into active caspases. In vitro binding experiments indicated that, like other IAP-family proteins, Survivin binds specifically to the terminal effector cell death proteases, caspase-3 and -7, but not to the proximal initiator protease caspase-8. Using a cell-free system in which cytosolic extracts were derived from control- or Survivin-transfected cells and where caspases were activated either by addition of cytochrome c and dATP or by adding recombinant active caspase-8, Survivin was able to substantially reduce caspase activity, as measured by cleavage of a tetrapeptide substrate, AspGluValAsp-aminofluorocoumarin. Similar results were obtained in intact cells when Survivin was overexpressed by gene transfection and caspase activation was induced by the anticancer drug etoposide. Sunivin was expressed in all 60 cancer cell lines analyzed, with highest levels in breast and lung cancers and lowest Levels in renal cancers. These findings indicate that Survivin, which is commonly expressed in human tumor cell lines, can bind the effector cell death proteases caspase-3 and -7 in vitro and inhibits caspase activity and cell death in cells exposed to diverse apoptotic stimuli. Although quantitative differences may exist, these observations suggest commonality in the mechanisms used by IAP-family proteins to suppress apoptosis. [References: 40]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel